SCHEMBL860465

SCHEMBL860465

O=C(O)[C@@H]1CCC=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23829629 1.00
Ammonia Solution, Strong SCHEMBL15875941 0.98
SCHEMBL574892 0.86
SCHEMBL13130776 0.86
Hydrochloric Acid SCHEMBL1703551 0.84 POLB (0.33)
SCHEMBL18556058 0.70 POLB (0.33)
SCHEMBL931732 0.67
SCHEMBL1326171 0.65
Acetic Acid SCHEMBL4904825 0.64
SCHEMBL17867453 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4537111-A2 MULTI-OMICS ASSESSMENT Prognomiq Inc (US) 2025-04-16 EP claimed
WO-2023240046-A2 MULTI-OMICS ASSESSMENT PrognomIQ, Inc. (US) 2023-12-14 WO claimed
US-20160355843-A1 METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE INVISTA NORTH AMERICA S.A.R.L. (US) 2016-12-08 US claimed
US-20160355844-A1 METHODS FOR BIOSYNTHESIZING 1,3 BUTADIENE INVISTA NORTH AMERICA S.A.R.L. (US) 2016-12-08 US claimed
CN-104769119-A Methods for biosynthesizing 1,3 butadiene INVISTA TECH SARL 2015-07-08 CN claimed
CN-104321434-A Methods for biosynthesizing 1,3butadiene INVISTA TECH SARL 2015-01-28 CN claimed
US-12577594-B2 Engineered microorganisms and methods for improved aldehyde dehydrogenase activity GENOMATICA, INC. (US) 2026-03-17 US disclosed
US-20260028651-A1 METHOD OF PRODUCING &amp; PROCESSING DIAMINES AGAIN BIO APS (DK) 2026-01-29 US disclosed
US-12503711-B2 Method of producing and processing diamines to a diamine free base using a carbonate intermediate and an engineered microorganism GENOMATICA, INC. (US) 2025-12-23 US disclosed
US-20250305013-A1 Methods and Compositions for Making Amide Compounds GENOMATICA, INC. (US) 2025-10-02 US disclosed
EP-4537111-A2 MULTI-OMICS ASSESSMENT Prognomiq Inc (US) 2025-04-16 EP disclosed
US-20250020651-A1 PERSONALIZED MODULATION THERAPY FOR CANCER FAETH THERAPEUTICS, INC. 2025-01-16 US disclosed
US-20240294885-A1 ENGINEERED ENZYMES AND METHODS OF MAKING AND USING AGAIN BIO APS (DK) 2024-09-05 US disclosed
WO-2011034397-A2 METHOD FOR PREDICTING DRUG TARGETS AND SCREENING FOR DRUGS FOR PATHOGENIC MICROORGANISMS USING ESSENTIAL METABOLITES 한국과학기술원 (KR) 2011-03-24 WO disclosed
US-20100317069-A1 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID AGAIN BIO APS (DK) 2010-12-16 US disclosed
US-20100280803-A1 Compositions and Methods for Modeling Saccharomyces cerevisiae Metabolism THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2010-11-04 US disclosed
US-7751981-B2 Articles of manufacture and methods for modeling Saccharomyces cerevisiae metabolism THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-07-06 US disclosed
US-20090259451-A1 REVERSE ENGINEERING GENOME-SCALE METABOLIC NETWORK RECONSTRUCTIONS FOR ORGANISMS WITH INCOMPLETE GENOME ANNOTATION AND DEVELOPING CONSTRAINTS USING PROTON FLUX STATES AND NUMERICALLY-DETERMINED SUB-SYSTEMS UNIVERSITY OF DELAWARE (US) 2009-10-15 US disclosed
US-20090186358-A1 Pathway Analysis of Cell Culture Phenotypes and Uses Thereof WYETH (US) 2009-07-23 US disclosed
EP-1249494-B1 PROCESS FOR THE BIOLOGICAL PRODUCTION OF L-PIPECOLIC ACID MERCIAN CORP (JP) 2009-02-18 EP disclosed